Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment.
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: BRMS1|Performance Status Zero to Two for Beginning the Study|Patient With a Maximum of One Chemotherapy|Patient With Progression After Taxanes
Interventions: DRUG: Lapatinib Vinorelbine|DRUG: Lapatinib Capecitabine|DRUG: Gemcitabine Lapatinib
Sponsor: Latin American Cooperative Oncology Group
Collaborators: GlaxoSmithKline